Education
About Us
Working with TipRanks
Follow Us
Zai Lab (ZLAB)
NASDAQ:ZLAB
Earnings Data
Report Date
Mar 03, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.23Last Year’s EPS
-0.8Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. Zai Lab showcased strong pipeline developments and success with VYVGART's market penetration in China. However, challenges such as slower commercial growth, supply constraints, and setbacks in the Bema program created significant headwinds. The company's focus on long-term growth and profitability remains strong.Company Guidance
Strong Efficacy Observed in Zoci Trials
Zoci (ZL-1310) showed an overall response rate of 68% and a disease control rate of 94% in Phase I trials for small cell lung cancer, with promising results in patients with brain metastases.
Significant Pipeline Development
Zai Lab has advanced several key programs, including Zoci entering a pivotal stage, and new trials for ZL-1503 and ZL-6201. Plans for global approvals and a robust pipeline were highlighted.
VYVGART Launch Success
VYVGART has become the #1 innovative drug by sales among all new launches in China over the past 2 years, with nearly 21,000 patients treated and penetration in gMG at 12%.
Financial Discipline and Growth
Despite slower-than-expected growth, Zai Lab's China business is commercially profitable, and the company reported a 14% year-over-year revenue growth, with a focus on financial discipline and efficiency.
ZLAB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ZLAB Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $24.80 | $23.15 | -6.65% |
Aug 07, 2025 | $38.72 | $34.08 | -11.98% |
May 08, 2025 | $28.36 | $29.14 | +2.75% |
Feb 27, 2025 | $35.07 | $34.38 | -1.97% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Zai Lab (ZLAB) report earnings?
Zai Lab (ZLAB) is schdueled to report earning on Mar 03, 2026, TBA (Confirmed).
What is Zai Lab (ZLAB) earnings time?
Zai Lab (ZLAB) earnings time is at Mar 03, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZLAB EPS forecast?
ZLAB EPS forecast for the fiscal quarter 2025 (Q4) is -0.23.